PHA 4123 First Exam Fall On my honor, I have neither given nor received unauthorized aid in doing this assignment.

Similar documents
The general concept of pharmacokinetics

Multicompartment Pharmacokinetic Models. Objectives. Multicompartment Models. 26 July Chapter 30 1

Nonlinear pharmacokinetics

MIDW 125 Math Review and Equation Sheet

Homework 1 (PHA 5127)

Marsh Model. Propofol

3 Results. Part I. 3.1 Base/primary model

Beka 2 Cpt: Two Compartment Model - Loading Dose And Maintenance Infusion

PHARMACOKINETIC DERIVATION OF RATES AND ORDERS OF REACTIONS IN MULTI- COMPARTMENT MODEL USING MATLAB

Using ODEs to Model Drug Concentrations within the Field of Pharmacokinetics

APPM 1350 Final Exam Fall 2017

Validation of the GastroPlus TM Software Tool and Applications

EUCAST. Linezolid Rationale for the EUCAST clinical breakpoints, version th November 2005

IVIVC Industry Perspective with Illustrative Examples

On drug transport after intravenous administration

Package clinpk. June 19, 2017

Description of UseCase models in MDL

Population Pharmacokinetics in Support of Analgesics and Anaesthetics Studies in

Fitting PK Models with SAS NLMIXED Procedure Halimu Haridona, PPD Inc., Beijing

TK Solver Case Study: Pharmacokinetics

Minto Model. Remifentanil

Nitroxoline Rationale for the NAK clinical breakpoints, version th October 2013

Introduction to PK/PD modelling - with focus on PK and stochastic differential equations

- 1 - By H. S Steyn, Statistical Consultation Services, North-West University (Potchefstroom Campus)

APPLICATION OF LAPLACE TRANSFORMS TO A PHARMACOKINETIC OPEN TWO-COMPARTMENT BODY MODEL

Tetracycline Rationale for the EUCAST clinical breakpoints, version th November 2009

Correction of the likelihood function as an alternative for imputing missing covariates. Wojciech Krzyzanski and An Vermeulen PAGE 2017 Budapest

Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.

PHYSIO-CHEMICAL PROPERTIES OF THE DRUG. It is the interaction of the drug with its environment

Journal home page:

Predicting the Onset of Nonlinear Pharmacokinetics

Chem. 6C Midterm 2 Version A November 13, 2007

IDENTIFICATION OF PARAMETERS FOR HILL CURVE USED IN GENERAL ANESTHESIA

UCLA: Math 3B Problem set 8 (solutions) Fall, 2016

Current approaches to covariate modeling

Chem. 6C Midterm 2 Version C November 13, 2007

Student s Printed Name:

Physical-Chemistry Factors Affecting Oral Absorption. Objectives. ph - Partition Theory. 27 September Chapter 23 1

PHA 5128 Answer CASE STUDY 3 Question #1: Model

Acid-Base balance. Acid : is the substance that donates H+, base : is the substance which receives or removes that H+.

Plot of Laser Operating Current as a Function of Time Laser Test Data

Practical: Acid-base balance

Supporting Information

Alkalosis or alkalemia arterial blood ph rises above Acidosis or acidemia arterial ph drops below 7.35 (physiological acidosis)

How Critical is the Duration of the Sampling Scheme for the Determination of Half-Life, Characterization of Exposure and Assessment of Bioequivalence?

Most common dose (mg) 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1. Maximum dose schedule (mg) 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1 1g x 1

Noncompartmental vs. Compartmental Approaches to Pharmacokinetic Data Analysis Paolo Vicini, Ph.D. Pfizer Global Research and Development David M.

Ionization of acids and bases

Problem solving steps

Principles of Drug Design

Modelling a complex input process in a population pharmacokinetic analysis: example of mavoglurant oral absorption in healthy subjects

Chemical calculations used in medicine (concentration, dilution)

OT Exam 1, August 9, 2002 Page 1 of 8. Occupational Therapy Physiology, Summer Examination 1. August 9, 2002

I pledge on my honor that I have neither given nor received unauthorized aid on this examination

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PRACTICE FINAL 2 MATH 16b

HPLC Determination of Antidepressants and their Metabolites in Plasma

MA/ST 810 Mathematical-Statistical Modeling and Analysis of Complex Systems

Reaction Rate (Kinetics) Reaction Rate

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD

Biotransport: Principles

Discussion Exercise 5: Analyzing Graphical Data

The Calculus Behind Generic Drug Equivalence

Science One Math. October 23, 2018

PHA 5127 Answers Homework 2 Fall 2001

Math 116 Practice for Exam 2

Lecture 22: PHARMACY CALCULATIONS for Technicians Preparing Injectable Medications

Math 151, Fall 2018 Common Exam 1 Version A

Math 1: Calculus with Algebra Midterm 2 Thursday, October 29. Circle your section number: 1 Freund 2 DeFord

Sign the pledge. On my honor, I have neither given nor received unauthorized aid on this Exam : 11. a b c d e. 1. a b c d e. 2.

- the flow of electrical charge from one point to the other is current.

In my opinion this paper can become suitable for publication, provided below issues are adequately addressed.

ANNOUNCEMENTS. HW5 is posted. It is due by 12:00 on 3/11.

Basic Concepts in Population Modeling, Simulation, and Model-Based Drug Development Part 2: Introduction to Pharmacokinetic Modeling Methods

APPLICATION OF CARBON ADSORBENTS IN RENAL FAILURE TREATMENT

UCLA: Math 3B Problem set 7 (solutions) Fall, 2017

CH MEDICINAL CHEMISTRY

Math 116 Practice for Exam 2

Physiology lecture (8): Acid Base regulation

Gentamicin Rationale for the EUCAST clinical breakpoints, version th February, 2009

Impact of saturable distribution in compartmental PK models: dynamics and practical use

Mouse Cholecystokinin (CCK) ELISA Kit

Study No: Title : Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Statistical Methods:

CHEMISTRY 107 Section 501 Final Exam Version A December 12, 2016 Dr. Larry Brown

EECS 312: Digital Integrated Circuits Midterm Exam 2 December 2010

CTP-656 Tablet Confirmed Superiority Of Pharmacokinetic Profile Relative To Kalydeco in Phase I Clinical Studies

Math Final Exam Review. 1. The following equation gives the rate at which the angle between two objects is changing during a game:

MATH 1324 (Finite Mathematics or Business Math I) Lecture Notes Author / Copyright: Kevin Pinegar

On approximate solutions in pharmacokinetics

Radiopharmaceuticals and Contrast Media. Lec: 7

y = sin(x) y = x x = 0 x = 1.

Chapter Four. Chapter Four

CHEMISTRY 102 FALL 2010 EXAM 2 FORM C SECTION 502 DR. KEENEY-KENNICUTT PART 1

Porcine Factor-related Apoptosis(FAS) ELISA Kit

Mathematical Material. Calculus: Objectives. Calculus. 17 January Calculus

Problem: Convert 25kg to ug. Problem: Convert 482mL to cl. Problem: How many micrograms are in a kilogram? Problem: How many ml are in 1 ounce?

CHAPTER 1: FIRST ORDER ORDINARY DIFFERENTIAL EQUATION

NONLINEAR MODELS IN MULTIVARIATE POPULATION BIOEQUIVALENCE TESTING

Math Exam 03 Review

Calculus I Midterm Exam. eftp Summer B, July 17, 2008

Transcription:

PHA 4123 First Exam Fall 1998 On my honor, I have neither given nor received unauthorized aid in doing this assignment. TYPED KEY Name Question 1. / pts 2. /2 pts 3. / pts 4. / pts. / pts 6. /10 pts 7. /10 pts 8. / pts 9. /1 pts 10. /10 pts 11. / pts Total /100 pts 1

1. ( pts)a patient is admitted with an acute theophylline overdose. A serum level is measured at 3 µg/ml. Assuming an 8 hour half-life and no further drug absorption, how long does it take for the serum level to drop to the upper limit of the therapeutic range (20 µg/ml)? t 1/2 = 8 h 0. 693 k = = 0.0866 h-1 t 1 / 2 C = Co e -k t 20 = 3 e -0.0866 t 20 3 = e 0. 0866 t 20 ln = 0. 0866 t 3 20 ln 3 t = = 11. 3 h 0. 0866 2

2. (2pts)A patient was given 80 mg gentamicin over 30 minutes (i.v.) from 7:30 to 8 am. During the elimination phase, two serum levels were measured: At 8:30 am At 3:00 pm 6.0 µg/ml 0.9 µg/ml Calculate: a. The elimination rate constant k k C1 ln 6 0. ln C 0. 9 = = 0 292 t t 6. 2 1 =. h 2 1 1 b. The elimination half-life 0. 693 0. 693 t 1 / 2 = = = 2. 4 h k 0. 292 c. The peak concentration at 8:00 am * = Cmax 6. 0 max = = 6. 94µ g / ml k t* 0. 292 0 e e C. d. The trough concentration at 3:30 pm * k t* 0. 292 0. Cmin = Cmin e = 0. 9 e = 0. 78µ g / ml e. The volume of distribution ( e k T 1 ) k T ( C C e ) 0. 292 0. ( 1 e ) 0. 292 0 ( 6. 94 0. 78 e ) = D 80 0. 136 d = = 47. 9 = 11. 9L k T 0. 292 0. 6. 266 V. max min 3

f. The clearance CL = k V d = 0.292 11.9 = 3.47 L/h or 7.9 ml/min 4

3. ( pts)what is the difference between a "third compartment" and "third space fluids"? Third compartment: Third space fluids: Space in the body that equilibrates slowly with the central compartment Accumulation of water in the tissue (e.g. ascites, edema) 4. ( pts) Explain why it is possible to use serum creatinine levels to determine renal function without measuring creatinine concentrations in the urine. Excretion Rate Clearance = Serum Level At steady state: Excretion Rate = Formation Rate Assumption: Creatinine Formation Rate is constant An empirical equation (Cockroft and Gault) is used to estimate creatinine clearance from serum creatinine.

. ( pts) Show for both high and low extraction drugs, how doubling the protein binding will affect the resulting unbound and total serum levels. What recommendations would you make for dose adjustments? Assume constant rate infusions and steady state. Doubled fb = fu High Low CL Q (-) fu CL int ( ) Css Ro Ro (-) Q fu CL ( ) fu Css fu Ro Q ( ) int Ro (-) CL int Dose ( ) (-) ( ) increase (-) no change ( ) decrease 6

6. (10 pts) After administration of a 400 mg theophylline sustained release product Q12H to a 70 kg patient, at steady state you measure a peak (after 4h) of 16 and a trough (after 12h) of 12 µg/ml. The average volume of distribution is 0. L/kg. a. Calculate the clearance CL D 400 400 = = = = 2. L / h AUC 16 + 12 168 38 12 2 b. Calculate the elimination half-life 0. 693 Vd 0. 693 3 t1 / 2 = = = 10. 2h CL 2. 38 c. Interpret the results This is a flip-flop case. Half-life cannot be calculated from the terminal slope. 7

7. (10 pts) Theophylline is administered as a constant rate infusion over 2 days. A plasma concentration profile is obtained which is shown in the two figures below. a. In the graph below, add the expected curve for a patient with equal clearance but only half the volume of distribution 30 2 20 1 10 0 0 20 40 60 80 100 Time (hours) b. In the graph below, add the expected curve in a smoker with equal volume of distribution but twice the clearance. 30 2 20 1 10 0 0 20 40 60 80 100 Time (hours) 8

8. ( pts) Define the pharmacokinetic parameters Vd ss and Vd area and explain, why Vd area is always larger than Vd ss. Vd ss Vd area Volume of distribution at steady state Central and peripheral compartment are in equilibrium (equal unbound concentrations) Volume of distribution during the elimination phase. There is a concentration gradient from the peripheral to the central compartment. (unbound concentration is higher in the peripheral compartment, lower in the central compartment) Lower concentration in central compartment larger V d Vd area > Vd ss 9

9. (1 pts) A theophylline infusion is started at a rate of 30 mg/h in a patient with the following parameters. CL = 3 L/h Vd = 40 L a. Calculate the expected steady state concentration C Ro 30 = = 10 g / ml CL 3 µ b. Calculate the expected concentration after 12 hours C = Ro CL ( e k t 0. 0712 1 ) = 10 ( 1 e ) =. 9µ g / ml k CL = = = 0. 07h Vd 40 3 1 c. Make a recommendation for dosing rate to bring the level at steady state to 1 µg/ml. Ro = C CL = 1 3 = 4 mg/h d. When therapy is discontinued, how long will the level stay above 10 µg/ml. C = Co e -k t 10 = 1 e -0.07 t 10 ln = 0. 07 t 1 t =.4 h 10

10. (10 pts) If propranolol is combined with phenobarbital, its intrinsic clearance can double due to enzyme induction. Discuss (in detail) how this interaction will affect the average steady state concentration of propranolol. a. after i.v. administration Ro Ro Css = = independent of CL int CL Q no change b. after oral administration F D Css = = CL τ ( 1 E) D CL τ = Q D = fu CL Q τ int F Q Q = 1 E = ~ fu CL + Q fu int CL int D fu CL int τ CL ~ Q if CL int is doubled, Css is cut in half 11

11. ( pts) In a study the volume of distribution for diazepam was found to be 91L in a group of normal weight subjects (average weight 61 kg) and 292 L in a group of obese subjects (average weight 104 kg). Discuss the results. Normal: Obese: 91L/61 kg 1. L/kg 292 L/104 kg 2.8 L/kg Increase in BW: ~ 70% In V d : ~ 220% Distribution in EBW more than in IBW more than proportional increase in V d due to high lipophilicity of diazepam 12